<DOC>
	<DOCNO>NCT00186433</DOCNO>
	<brief_summary>1 . To determine prognostic implication plasma Epstein-Bar Virus ( EBV ) DNA concentration , measure quantitative polymerase chain reaction ( PCR ) patient nasopharyngeal carcinoma ( NPC ) . 2 . To relate pretreatment plasma EBV DNA concentration WHO classification tumor endemic non-endemic area . 3 . To determine whether pretreatment plasma EBV DNA serve prognostic factor endemic non-endemic patient population .</brief_summary>
	<brief_title>A Longitudinal Study Plasma EBV DNA Nasopharyngeal Carcinoma From Both Endemic Non-Endemic Patient Populations</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Mouth Neoplasms</mesh_term>
	<mesh_term>Lip Neoplasms</mesh_term>
	<criteria>Having new diagnosis Nasopharyngeal carcinoma . Being treat either radiotherapy chemoradiotherapy condition . Age &lt; 18 since NPC rare condition age group may different biological behavior Patients unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>